Samorita Hospital Limited (DSE:SAMORITA)
Bangladesh · Delayed Price · Currency is BDT 82.90
+0.40 (0.48%)
At close: Nov 3, 2026
Samorita Hospital Financials Overview
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 426.58 | 401.37 | 378.39 | 334.27 | 338.09 | 393.62 |
Revenue Growth | 9.15% | 6.07% | 13.20% | -1.13% | -14.11% | 22.53% |
Gross Profit Gross Profit Growth | 247.88 | 224.29 | 215.72 | 188.5 | 190.04 | 220.87 |
Operating Income Operating Income Growth | 18.25 | 16.9 | 17.57 | 3.78 | 24.41 | 49.17 |
Net Income Net Income Growth | 10.73 | 13.53 | 12.2 | 0.72 | 16.29 | 42.09 |
Earnings Per Share EPS Growth | 0.49 | 0.62 | 0.56 | 0.03 | 0.75 | 1.93 |
EPS Growth | -7.81% | 10.91% | 1593.42% | -95.58% | -61.29% | 1193.89% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Medical Services Medical Services Growth | 196.44 | 180.04 | 174.64 | 147.27 | 147.61 | 182.59 |
Diagnostic Diagnostic Growth | 108.21 | 102.68 | 97.76 | 88.1 | 84.78 | 77.71 |
Pharmacy Pharmacy Growth | 121.93 | 118.64 | 105.99 | 98.9 | 105.7 | 133.32 |
Total Total Growth | 426.58 | 401.37 | 378.39 | 334.27 | 338.09 | 393.62 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 47.94 | 38.22 | 52.74 | 44.37 | 69.46 | 107.31 |
Total Debt Total Debt Growth | 3.93 | 1.95 | 22.63 | 42.33 | 60.63 | 56.5 |
Net Cash (Debt) Net Cash Growth | 44.01 | 36.27 | 30.11 | 2.04 | 8.83 | 50.8 |
Net Cash Growth | 26.66% | 20.43% | 1378.22% | -76.94% | -82.62% | -23.82% |
Net Cash Per Share Net Cash Per Share Growth | 2.02 | 1.66 | 1.38 | 0.09 | 0.41 | 2.33 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 46.09 | 37.47 | 44.45 | 26.51 | 34.99 | 60.07 |
Capital Expenditures CapEx Growth | -26.08 | -21.06 | -17.8 | -26.55 | -46.25 | -81.69 |
Free Cash Flow Free Cash Flow Growth | 20 | 16.41 | 26.65 | -0.04 | -11.26 | -21.62 |
Free Cash Flow Growth | 272.24% | -38.44% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 58.11% | 55.88% | 57.01% | 56.39% | 56.21% | 56.11% |
Operating Margin | 4.28% | 4.21% | 4.64% | 1.13% | 7.22% | 12.49% |
Pretax Margin | 4.95% | 4.50% | 4.47% | 0.93% | 7.20% | 13.85% |
Profit Margin | 2.51% | 3.37% | 3.22% | 0.22% | 4.82% | 10.69% |
FCF Margin | 4.69% | 4.09% | 7.04% | -0.01% | -3.33% | -5.49% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.500 | 0.500 | - | 0.433 | 0.866 |
Dividend Per Share Growth | 100.00% | 0% | - | - | -50.00% | - |
Dividend Yield | 0.60% | 0.89% | 0.70% | - | 0.68% | 1.49% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 168.45 | 91.04 | 126.70 | 2052.27 | 85.15 | 30.14 |
P/FCF Ratio | 90.35 | 75.07 | 58.00 | - | - | - |
PS Ratio | 4.24 | 3.07 | 4.09 | 4.42 | 4.10 | 3.22 |